{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:04:24Z","timestamp":1772449464920,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03136-4","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:02:56Z","timestamp":1697464976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of early administration of tolvaptan on pleural effusion post-hepatectomy"],"prefix":"10.1007","volume":"408","author":[{"given":"Hiroya","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Maehira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhito","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Takebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaji","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"1","key":"3136_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/bjs.4018","volume":"90","author":"AC Wei","year":"2003","unstructured":"Wei AC, Tung-Ping Poon R, Fan ST, Wong J (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90(1):33\u201341. https:\/\/doi.org\/10.1002\/bjs.4018","journal-title":"Br J Surg"},{"issue":"4","key":"3136_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00268-016-3826-1","volume":"41","author":"H Uchiyama","year":"2017","unstructured":"Uchiyama H, Harimoto N, Itoh S, Yoshizumi T, Ikegami T, Maehara Y (2017) Pleural effusion after hepatectomy for hepatocellular carcinoma: risk factor analyses and its impact on oncological outcomes. World J Surg 41(4):1089\u20131099. https:\/\/doi.org\/10.1007\/s00268-016-3826-1","journal-title":"World J Surg"},{"issue":"6","key":"3136_CR3","doi-asserted-by":"publisher","first-page":"27502","DOI":"10.25011\/cim.v39i6.27502","volume":"39","author":"T Yakar","year":"2016","unstructured":"Yakar T, Demir M, Dogan O, Parlakgumus A, Ozer B, Serin E (2016) High Dose oral furosemide with salt ingestion in the treatment of refractory ascites of liver cirrhosis. Clin Invest Med 39(6):27502","journal-title":"Clin Invest Med"},{"issue":"10","key":"3136_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jhbp.276","volume":"22","author":"T Takahara","year":"2015","unstructured":"Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N, Hatano E, Tanahashi Y, Mizuguchi T, Kamiyama T, Ikeda T, Tanaka S, Taniai N, Baba H, Tanabe M, Kokudo N, Konishi M, Uemoto S, Sugioka A, Hirata K, Taketomi A, Maehara Y, Kubo S, Uchida E, Miyata H, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T (2015) Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepatobiliary Pancreat Sci 22(10):721\u2013727. https:\/\/doi.org\/10.1002\/jhbp.276","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"3","key":"3136_CR5","first-page":"375","volume":"4","author":"JJ Yan","year":"2005","unstructured":"Yan JJ, Zhang XH, Chu KJ, Huang L, Zhou FG, Yan YQ (2005) Prevention and management of pleural effusion following hepatectomy in primary liver cancer. Hepatobiliary Pancreat Dis Int 4(3):375\u2013378","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"3136_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00534-008-0039-5","volume":"16","author":"T Ikegami","year":"2009","unstructured":"Ikegami T, Shimada M, Imura S, Nakamura T, Kawahito S, Morine Y, Kanemura H, Hanaoka J (2009) Argon gas embolism in the application of laparoscopic microwave coagulation therapy. J Hepatobiliary Pancreat Surg 16(3):394\u2013398. https:\/\/doi.org\/10.1007\/s00534-008-0039-5","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"7","key":"3136_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/jgh.14524","volume":"34","author":"T Iwamoto","year":"2019","unstructured":"Iwamoto T, Maeda M, Saeki I, Hidaka I, Tajima K, Ishikawa T, Takami T, Sakaida I (2019) Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites. J Gastroenterol Hepatol 34(7):1231\u20131235. https:\/\/doi.org\/10.1111\/jgh.14524","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"3136_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/hepr.12099","volume":"44","author":"K Okita","year":"2014","unstructured":"Okita K, Kawazoe S, Hasebe C, Kajimura K, Kaneko A, Okada M, Sakaida I (2014) Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: a randomized, double-blind, placebo-controlled trial. Hepatol Res 44(1):83\u201391. https:\/\/doi.org\/10.1111\/hepr.12099","journal-title":"Hepatol Res"},{"issue":"1","key":"3136_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/hepr.12098","volume":"44","author":"I Sakaida","year":"2014","unstructured":"Sakaida I, Kawazoe S, Kajimura K, Saito T, Okuse C, Takaguchi K, Okada M, Okita K (2014) Tolvaptan for improvement of hepatic edema: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Hepatol Res 44(1):73\u201382. https:\/\/doi.org\/10.1111\/hepr.12098","journal-title":"Hepatol Res"},{"issue":"3","key":"3136_CR10","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3892\/etm.2020.9007","volume":"20","author":"H Chen","year":"2020","unstructured":"Chen H, Jiang W, Li X, Meng Z, Chen H, Li J, Wang J, Zhao X (2020) Efficacy of tolvaptan for fluid management after cardiovascular surgery: a systematic review and meta-analysis of randomized control trials. Exp Ther Med 20(3):2585\u20132592. https:\/\/doi.org\/10.3892\/etm.2020.9007","journal-title":"Exp Ther Med"},{"issue":"5","key":"3136_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","volume":"149","author":"M Koch","year":"2011","unstructured":"Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, B\u00fcchler MW, Weitz J (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149(5):680\u2013688. https:\/\/doi.org\/10.1016\/j.surg.2010.12.002","journal-title":"Surgery"},{"issue":"5","key":"3136_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, B\u00fcchler MW, Weitz J (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713\u2013724. https:\/\/doi.org\/10.1016\/j.surg.2010.10.001","journal-title":"Surgery"},{"issue":"8","key":"3136_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berr\u00edos-Torres","year":"2017","unstructured":"Berr\u00edos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke CE, Morgan S, Solomkin JS, Mazuski JE, Dellinger EP, Itani KMF, Berbari EF, Segreti J, Parvizi J, Blanchard J, Allen G, Kluytmans J, Donlan R (2017) Schecter WP (2017) Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg 152(8):784\u2013791. https:\/\/doi.org\/10.1001\/jamasurg.2017.0904","journal-title":"JAMA Surg"},{"issue":"2","key":"3136_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"issue":"2","key":"3136_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santiba\u00f1es E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"issue":"8","key":"3136_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00535-020-01691-x","volume":"55","author":"I Sakaida","year":"2020","unstructured":"Sakaida I, Terai S, Kurosaki M, Okada M, Hirano T, Fukuta Y (2020) Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study). J Gastroenterol 55(8):800\u2013810. https:\/\/doi.org\/10.1007\/s00535-020-01691-x","journal-title":"J Gastroenterol"},{"issue":"3","key":"3136_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/hep.22418","volume":"48","author":"P Gin\u00e8s","year":"2008","unstructured":"Gin\u00e8s P, Guevara M (2008) Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology 48(3):1002\u20131010. https:\/\/doi.org\/10.1002\/hep.22418","journal-title":"Hepatology"},{"issue":"6","key":"3136_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/hep.22853","volume":"49","author":"BA Runyon","year":"2009","unstructured":"Runyon BA (2009) Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49(6):2087\u20132107. https:\/\/doi.org\/10.1002\/hep.22853","journal-title":"Hepatology"},{"issue":"3","key":"3136_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53(3):397\u2013417. https:\/\/doi.org\/10.1016\/j.jhep.2010.05.004","journal-title":"J Hepatol"},{"issue":"11","key":"3136_CR20","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/hepr.12852","volume":"47","author":"I Sakaida","year":"2017","unstructured":"Sakaida I, Terai S, Kurosaki M, Yasuda M, Okada M, Bando K, Fukuta Y (2017) Effectiveness and safety of tolvaptan in liver cirrhosis patients with edema: Interim results of post-marketing surveillance of tolvaptan in liver cirrhosis (START study). Hepatol Res 47(11):1137\u20131146. https:\/\/doi.org\/10.1111\/hepr.12852","journal-title":"Hepatol Res"},{"issue":"5","key":"3136_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1253\/circj.CJ-17-0986","volume":"82","author":"K Kinugawa","year":"2018","unstructured":"Kinugawa K, Sato N, Inomata T, Yasuda M, Shibasaki Y, Shimakawa T (2018) Novel risk score efficiently prevents tolvaptan-induced hypernatremic events in patients with heart failure. Circ J 82(5):1344\u20131350. https:\/\/doi.org\/10.1253\/circj.CJ-17-0986","journal-title":"Circ J"},{"issue":"4","key":"3136_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1253\/circj.CJ-17-0967","volume":"82","author":"Y Kishimoto","year":"2018","unstructured":"Kishimoto Y, Nakamura Y, Harada S, Onohara T, Kishimoto S, Kurashiki T, Fujiwara Y, Nishimura M (2018) Can Tolvaptan protect renal function in the early postoperative period of cardiac surgery? - results of a single-center randomized controlled study. Circ J 82(4):999\u20131007. https:\/\/doi.org\/10.1253\/circj.CJ-17-0967","journal-title":"Circ J"},{"key":"3136_CR23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ijcard.2016.06.156","volume":"220","author":"K Matsuyama","year":"2016","unstructured":"Matsuyama K, Koizumi N, Nishibe T, Iwasaki T, Iwahasi T, Toguchi K, Takahashi S, Iwahori A, Maruno K, Ogino H (2016) Effects of short-term administration of tolvaptan after open heart surgery. Int J Cardiol 220:192\u2013195. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.156","journal-title":"Int J Cardiol"},{"issue":"1","key":"3136_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12872-016-0341-0","volume":"16","author":"TS Kato","year":"2016","unstructured":"Kato TS, Nakamura H, Murata M, Kuroda K, Suzuki H, Yokoyama Y, Shimada A, Matsushita S, Yamamoto T, Amano A (2016) The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery. BMC Cardiovasc Disord 16(1):181. https:\/\/doi.org\/10.1186\/s12872-016-0341-0","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"3136_CR25","first-page":"111","volume":"62","author":"Y Suehiro","year":"2016","unstructured":"Suehiro Y, Hosono M, Shibata T, Sasaki Y, Hirai H, Nakahira A, Kubota Y, Kaku D, Suehiro S (2016) Efficacy and safety evaluation of Tolvaptan on management of fluid balance after cardiovascular surgery using cardiopulmonary bypass. Osaka City Med J 62(2):111\u2013119","journal-title":"Osaka City Med J"},{"issue":"1","key":"3136_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000501267","volume":"38","author":"H Uojima","year":"2020","unstructured":"Uojima H, Hidaka H, Tanaka Y, Wada N, Kubota K, Nakazawa T, Shibuya A, Sung JH, Kako M, Koizumi W (2020) Furosemide dose changes associated with furosemide\/tolvaptan combination therapy in patients with cirrhosis. Dig Dis 38(1):38\u201345. https:\/\/doi.org\/10.1159\/000501267","journal-title":"Dig Dis"},{"issue":"1","key":"3136_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40792-020-00825-w","volume":"6","author":"H Iida","year":"2020","unstructured":"Iida H, Maehira H, Mori H, Maekawa T, Tani M (2020) Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report. Surg Case Rep 6(1):61. https:\/\/doi.org\/10.1186\/s40792-020-00825-w","journal-title":"Surg Case Rep"},{"issue":"2","key":"3136_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1536\/ihj.14-332","volume":"56","author":"K Kinugawa","year":"2015","unstructured":"Kinugawa K, Inomata T, Sato N, Yasuda M, Shimakawa T, Bando K, Mizuguchi K (2015) Effectiveness and adverse events of tolvaptan in octogenarians with heart failure Interim analyses of Samsca Post-Marketing Surveillance In Heart faiLurE (SMILE study). Int Heart J. 56(2):137\u2013143. https:\/\/doi.org\/10.1536\/ihj.14-332","journal-title":"Int Heart J."},{"issue":"10","key":"3136_CR29","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00228-016-2091-4","volume":"72","author":"K Hirai","year":"2016","unstructured":"Hirai K, Shimomura T, Moriwaki H, Ishii H, Shimoshikiryo T, Tsuji D, Inoue K, Kadoiri T, Itoh K (2016) Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment. Eur J Clin Pharmacol 72(10):1177\u20131183. https:\/\/doi.org\/10.1007\/s00228-016-2091-4","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03136-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03136-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03136-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:24:12Z","timestamp":1705577052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03136-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3136"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03136-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2685444\/v1","asserted-by":"object"}]},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study conformed to the Clinical Research Guidelines and was approved by the ethical committee of our institution (institutional approval number: R2019-164). It was also registered retrospectively in the Japan Primary Registries Network (UMIN ID number: 000051266). Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}